Effect of Imaginary Resisted Therapy Versus Physical Resisted Therapy on Hemiplegic Cerebral Palsy
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Aug 18, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of exercises to see which one helps improve hand grip strength in children with hemiplegic cerebral palsy, a condition that affects one side of the body. The researchers want to compare "imaginary resisted exercises," where children imagine doing a workout, against "physical resisted exercises," which involve actual physical movement. The goal is to find out which method is more effective for improving strength in the affected hand.
The study is looking for children aged 6 to 12 years who have congenital hemiplegia (a type of cerebral palsy present at birth) and do not use their affected arm much. To join, kids should have a certain level of ability to use their hands and have a specific level of muscle tightness. However, children with certain conditions, like severe muscle stiffness, recent surgeries, or uncontrolled epilepsy, will not be eligible to participate. If eligible, children will engage in either type of exercise over the course of the trial, and the researchers will monitor their progress in hand strength. This study is currently recruiting participants, and it's a great opportunity to potentially help improve treatment options for hemiplegic cerebral palsy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Congenital infantile hemiplegia.
- • Aged between 6 and 12 years.
- • Lack of use of the affected upper limb.
- • Level I-III of the Manual Ability Classification System (MACS).
- • Students scoring of Modified Ashworth Scale should be 3 or less than 3 out of 5 for the same muscle groups of previously mentioned movements.
- Exclusion Criteria:
- • Low cognitive level compatible with attending a special education school.
- • Presence of contractures in the affected upper limb affecting the functional movement.
- • Surgery in the six months previously to the treatment.
- • Botulinum toxin in the two months previously to or during the intervention.
- • Pharmacologically uncontrolled epilepsy
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Dr. Nosheen Manzoor, MS OMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported